1006 related articles for article (PubMed ID: 17540598)
1. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
3. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
4. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
5. p53 enters the microRNA world.
Hermeking H
Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
Chang TC; Wentzel EA; Kent OA; Ramachandran K; Mullendore M; Lee KH; Feldmann G; Yamakuchi M; Ferlito M; Lowenstein CJ; Arking DE; Beer MA; Maitra A; Mendell JT
Mol Cell; 2007 Jun; 26(5):745-52. PubMed ID: 17540599
[TBL] [Abstract][Full Text] [Related]
7. Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site.
Feinberg-Gorenshtein G; Avigad S; Jeison M; Halevy-Berco G; Mardoukh J; Luria D; Ash S; Steinberg R; Weizman A; Yaniv I
Genes Chromosomes Cancer; 2009 Jul; 48(7):539-43. PubMed ID: 19373781
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
[TBL] [Abstract][Full Text] [Related]
10. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
[TBL] [Abstract][Full Text] [Related]
11. The miR-34 family in cancer and apoptosis.
Hermeking H
Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
[TBL] [Abstract][Full Text] [Related]
12. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
[TBL] [Abstract][Full Text] [Related]
13. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; ViƱolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
14. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
15. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
17. OncomiRs: the discovery and progress of microRNAs in cancers.
Cho WC
Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
Welch C; Chen Y; Stallings RL
Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
[TBL] [Abstract][Full Text] [Related]
19. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
[TBL] [Abstract][Full Text] [Related]
20. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]